老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Global X Genomics & Biotechnology ETF
66.40
-0.5220
-0.78%
盤後：
66.19
-0.2080
-0.31%
19:30 EDT
成交量：
2.48萬
成交額：
164.92萬
市值：
9,990.99萬
市盈率：
- -
高：
66.96
開：
66.96
低：
66.07
收：
66.92
52周最高：
68.00
52周最低：
37.25
股本：
150.47萬
流通股本：
150.47萬
量比：
0.98
換手率：
1.65%
股息：
0.65
股息率：
0.98%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Moderna與CEPI達成協議：承諾以可及定價向中低收入國家供應至少50萬劑mRNA-1469疫苗
美股速递
·
08/04
Moderna啓動邦迪布吉奧埃博拉疫苗的首項人體試驗
路透中文
·
08/04
Moderna在加拿大開展mRNA-1469一期臨床試驗，深化與流行病防範創新聯盟的合作
美股速递
·
08/04
AI賦能肺癌早篩診療升級 國產醫療機器人加速精準醫療落地 真健康醫療(02697)迎行業發展機遇
智通财经
·
08/04
美銀全球研究：將Moderna(MRNA.US)目標價從38美元上調至40美元。
智通财经
·
08/03
Twist Bioscience Corp：第四季度營收預計約1.23億至1.24億美元
美股速递
·
08/03
基因編輯的商業化：一款產品220萬美元，A股超20家概念股，但多數只賣工具
红星资本局
·
08/03
美國研究綜述-艾伯維、亞馬遜、伊利姆納
路透中文
·
08/03
莫德納股價下跌，因諾如病毒疫苗試驗遭遇挫折
路透中文
·
08/01
莫德納疫苗管線逐漸清晰，新藥前景牽動市場
投资观察
·
07/31
更正-在等待美國就流感疫苗作出關鍵決定之際，Moderna的季度營收超出預期
路透中文
·
07/31
Moderna第二季度每股收益-1.97美元，優於IBES預期的-2.08美元
投资观察
·
07/31
Moderna(MRNA.US)盤前跌5.7%二季度營收略低於預期。
智通财经
·
07/31
Moderna宣佈：mRNA-1403 III期中期分析未達早期成功統計標準，正籌備新增隊列招募
美股速递
·
07/31
Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點
美股速递
·
07/31
【特約大V】龔成：最新分析，6個高增長行業
金吾财讯
·
07/31
今日關注要點——7月31日（星期五）
路透中文
·
07/31
默克、惠康與一家全球衞生組織合作，共同研製埃博拉疫苗以用於臨床試驗
路透中文
·
07/30
美國食品藥品監督管理局（FDA）批准了Freenome公司用於結直腸癌篩查的血液檢測
路透中文
·
07/27
美股異動 | CRISPR基因編輯公司Scribe Therapeutics(SCTX.US)登陸美股市場 開盤後升逾59%
智通财经
·
07/24
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/GNOM/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":66.398,"timestamp":1789761600000,"preClose":66.92,"halted":0,"volume":24845,"hourTrading":{"tag":"盘后","latestPrice":66.19,"preClose":66.398,"latestTime":"19:30 EDT","volume":17,"amount":1127.886,"timestamp":1789774206560,"change":-0.208,"changeRate":-0.003133,"amplitude":0},"delay":0,"changeRate":-0.007800358637178804,"floatShares":1504713,"shares":1504713,"eps":0,"marketStatus":"休市中","change":-0.522,"latestTime":"09-18 16:00:00 EDT","open":66.96,"high":66.96,"low":66.066,"amount":1649200.1682,"amplitude":0.013359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":66.92,"sharesOutstanding":1094672,"nav":66.45,"aum":99990068.69,"dividendRate":0.009765,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":68.03,"preClose":66.92,"latestTime":"07:44 EDT","volume":1,"amount":68.03,"timestamp":1789731862440,"change":1.11,"changeRate":0.016587,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":66.19,"preClose":66.398,"latestTime":"19:30 EDT","volume":17,"amount":1127.886,"timestamp":1789774206560,"change":-0.208,"changeRate":-0.003133,"amplitude":0},"volumeRatio":0.9764734550142276,"impliedVol":0.3077,"impliedVolPercentile":0.8048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1504713,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9764734550142276,"shares":1504713,"dividePrice":0.6484,"high":66.96,"amplitude":0.013359,"preClose":66.92,"low":66.066,"week52Low":37.25,"pbRate":"--","week52High":68,"institutionHeld":0,"latestPrice":66.398,"eps":0,"divideRate":0.009765,"volume":24845,"delay":0,"ttmEps":0,"open":66.96,"prevYearClose":45.4562,"prevWeekClose":62.2188,"prevMonthClose":64.4209,"prevQuarterClose":56.834,"fiveDayClose":62.2188,"twentyDayClose":64.9029,"sixtyDayClose":53.7792},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171618213","title":"Moderna與CEPI達成協議：承諾以可及定價向中低收入國家供應至少50萬劑mRNA-1469疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1171618213","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171618213?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 23:01","pubTimestamp":1785855677,"startTime":"0","endTime":"0","summary":"在最新签署的CEPI合作协议框架下，Moderna公司作出明确承诺——将以可及定价向中低收入国家提供至少50万剂mRNA-1469疫苗。此举不仅彰显了企业在全球公共卫生领域的责任担当，更意味着该创新型疫苗有望加速惠及资源匮乏地区的脆弱人群。通过这一协议，Moderna旨在平衡商业利益与公平获取，确保疫苗供应链的韧性与可负担性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4548","MRNA","BK4568","MRNY","BK4588","GNOM","MRNX","IDNA","WDNA","BK4534","BK4501","BK4139","BK4585","BK4533","BK4532","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656529557","title":"Moderna啓動邦迪布吉奧埃博拉疫苗的首項人體試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2656529557","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656529557?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 23:01","pubTimestamp":1785855671,"startTime":"0","endTime":"0","summary":"Moderna启动邦迪布吉奥埃博拉疫苗的首项人体试验路透8月4日-莫德纳公司周二表示，已开始对预防邦迪布吉奥埃博拉病毒的实验性疫苗进行首次人体试验。该埃博拉病毒株迄今已造成超过1,650人死亡，目前尚无获批的疫苗。莫德纳公司表示，如果该疫苗最终获得批准，根据其与CEPI达成的协议，计划以可负担价格向中低收入国家提供至少50万剂疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4S4411I3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","BK4139","BK4532","IDNA","MRNY","MRNA","BK4501","BK4534","BK4551","BK4588","BK4548","BK4533","BK4568","BK4585","WDNA","LGHT","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181954568","title":"Moderna在加拿大開展mRNA-1469一期臨床試驗，深化與流行病防範創新聯盟的合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1181954568","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181954568?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 23:00","pubTimestamp":1785855615,"startTime":"0","endTime":"0","summary":"Moderna宣布，作为其与流行病防范创新联盟（CEPI）扩大合作的一部分，已在加拿大正式启动mRNA-1469候选疫苗的一期临床试验。这一举措标志着双方在应对全球公共卫生威胁方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","BK4585","BK4548","BK4588","BK4532","BK4568","GNOM","MRNX","BK4551","IDNA","MRNY","BK4534","MRNA","BK4501","BK4139","BK4533","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656584164","title":"AI賦能肺癌早篩診療升級 國產醫療機器人加速精準醫療落地 真健康醫療(02697)迎行業發展機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2656584164","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656584164?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 12:58","pubTimestamp":1785819500,"startTime":"0","endTime":"0","summary":"业内人士认为，随着AI影像识别、三维重建、机器人辅助介入等技术持续成熟，医疗机器人产业正加速迈入商业化应用阶段，覆盖肺癌、骨科、神经外科等多个高价值赛道，行业成长空间广阔。受益于医疗智能化升级趋势，“穿刺手术机器人第一股”真健康医疗持续推进人工智能与数字医疗布局。随着国家持续推动医疗数字化建设，以及AI医疗机器人、精准诊疗等新技术加速落地，真健康医疗有望受益于行业景气度提升，进一步打开长期成长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GDOC","BMED","CHAT","HTEC","KOMP","02697","BK1100","WDNA","HELX","GNOM","AGIX","DTEC","IDNA","SYNB","AIPO","159891","QTOC","TYNE","GNMX","XT","VTHR","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656376004","title":"美銀全球研究：將Moderna(MRNA.US)目標價從38美元上調至40美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2656376004","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656376004?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 20:14","pubTimestamp":1785759295,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4532","BK4568","MRNY","BK4501","BK4588","BK4551","IDNA","LGHT","BK4585","MRNA","UDN","BK4534","GNOM","MRNX","BK4533","BK4548","UUP","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172365141","title":"Twist Bioscience Corp：第四季度營收預計約1.23億至1.24億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172365141","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172365141?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 19:18","pubTimestamp":1785755887,"startTime":"0","endTime":"0","summary":"Twist Bioscience Corp 公布了其第四季度业绩展望。公司预计，该季度的总营收将介于约1.23亿美元至1.24亿美元之间。这一预期区间反映了公司对当前业务运营状况的评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","ARKG","GNOM","BK4585","IDNA","TWST","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656037309","title":"基因編輯的商業化：一款產品220萬美元，A股超20家概念股，但多數只賣工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2656037309","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656037309?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 18:53","pubTimestamp":1785754410,"startTime":"0","endTime":"0","summary":"红星资本局8月3日消息，近日，一名6岁女童在接受基因编辑临床试验后死亡的事件，将“基因编辑”这项前沿技术推向公众视野。红星资本局注意到，近年来，基因编辑这一创新医疗技术在β-地中海贫血、镰状细胞贫血病等遗传性疾病治疗领域已有成熟应用，国外也有获批上市的药物。在国内，目前布局基因编辑疗法的主要为新兴的生物科技公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608033829926851.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608033829926851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XT","BMED","DTEC","KOMP","NBDS","399300","GNOM","HELX","TARK","159982","WDNA","SYNB","FWD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656329979","title":"美國研究綜述-艾伯維、亞馬遜、伊利姆納","url":"https://stock-news.laohu8.com/highlight/detail?id=2656329979","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656329979?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 15:47","pubTimestamp":1785743242,"startTime":"0","endTime":"0","summary":"美国研究综述-艾伯维、亚马逊、伊利姆纳路透8月3日-周一，华尔街证券分析师下调了包括艾伯维、亚马逊和伊利姆纳在内的多家美国上市公司评级及目标股价。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4S4400J4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LAUR","TEM","TFNS","BN","GTES","LH","RTH","VCYT","VLY","PRM","AGIO","IYH","NBN","FHN","KOD","PFG","PJP","IONS","GNMX","LBO","LNC","BBT","GNOM","ILDR","OMCL","FLG","ABBV","FTXH","ILMN","ARES","BEPC","IR","MSA","MTZ","TW","LSEG.UK","CHD","WANT","INO","FULT","CL","IYF","CBNA","AMZN","CATY","ONLN","CFR","IXJ","TRUH","BOKF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656956093","title":"莫德納股價下跌，因諾如病毒疫苗試驗遭遇挫折","url":"https://stock-news.laohu8.com/highlight/detail?id=2656956093","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656956093?lang=zh_tw&edition=fundamental","pubTime":"2026-08-01 02:27","pubTimestamp":1785522454,"startTime":"0","endTime":"0","summary":"BUZZ-莫德纳股价下跌，因诺如病毒疫苗试验遭遇挫折7月31日-** 疫苗制造商莫德纳（Moderna）MRNA.O的股价下跌约4%，至55.71美元** 该公司表示，在晚期临床试验的中期分析中，其诺如病毒候选疫苗未能达到早期成功的统计学基准 (link)** 由于符合研究主要目标的病例积累速度低于预期，Moderna将把诺如病毒疫苗试验延续至下一个流行季节** 多伦多道明 Cowen 分析师泰勒","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4S43X26E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","MRNY","GNOM","LGHT","BK4534","BK4548","IDNA","BK4568","MRNX","BK4585","BK4533","MRNA","BK4551","WDNA","BK4501","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191889577","title":"莫德納疫苗管線逐漸清晰，新藥前景牽動市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1191889577","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191889577?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 21:59","pubTimestamp":1785506345,"startTime":"0","endTime":"0","summary":"莫德纳公布了第二季度财报，营收达1.45亿美元，较去年同期微增约2%。然而，摩根大通的分析师指出，该公司的新冠疫苗业务高度集中于下半年。“我们预计市场不会过分关注本季度的具体营收数字，”分析师在研究报告中写道。至于管线进展，其一款诺如病毒疫苗在正在进行的关键临床试验中未达预期。与此同时，莫德纳预计其新型季节性流感疫苗有望在8月5日获得批准。“这意味着莫德纳将迎来第五个获批产品，但我们认为，仅凭此尚不足以推动公司踏上全新发展轨道，”分析师们评论道。莫德纳股价当日上涨1%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GNOM","BK4534","MRNA","BK4568","BK4588","BK4533","MRNX","MRNY","BK4532","LGHT","BK4501","BK4139","BK4548","IDNA","BK4551","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655638003","title":"更正-在等待美國就流感疫苗作出關鍵決定之際，Moderna的季度營收超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2655638003","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655638003?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:18","pubTimestamp":1785496718,"startTime":"0","endTime":"0","summary":"更新版 3-更正-在等待美国就流感疫苗作出关键决定之际，Moderna的季度营收超出预期诺如病毒候选疫苗面临临床试验挫折FDA将于8月5日前就流感疫苗作出决定Co下调年度研发支出预期第7段和第13段新增图表及高管评论，第10段和第15段新增分析师评论Mariam Sunny/Christy Santhosh路透7月31日-莫德纳公司周五公布的第二季度营收超出华尔街预期，这得益于疫苗合作款项及其新冠疫苗的国际销售收入，而投资者正等待美国监管机构对其流感疫苗的关键决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4T43X19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU2357627491.SGD","JDOC","LU2023250504.SGD","BK4588","LU1093756168.USD","GDOC","LU2112291526.USD","LU2491050071.SGD","MRNY","LU0980610538.SGD","IDNA","IHE","IXJ","LGHT","LU0289739699.SGD","FHLC","RXL","MRNX","MRK","LU0823416689.USD","IE0002141913.USD","LU0320765646.SGD","GNOM","LU0070302665.USD","IYH","LU1162221912.USD","LU2433249047.HKD","LU1035773651.USD","LU1571399168.USD","LU2361045086.USD","LU0058720904.USD","SG9999014575.USD","WDNA","HRTS","LU0265550359.USD","LU1917777945.USD","PAWZ","LU2125154935.USD","MRNA","XLV","SG9999013999.USD","BMED","VHT","PPH","LU1699723380.USD","BK4568","TRUH","FTXH","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191369993","title":"Moderna第二季度每股收益-1.97美元，優於IBES預期的-2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191369993","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191369993?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:16","pubTimestamp":1785496607,"startTime":"0","endTime":"0","summary":"Moderna公布的2026年第二季度财报显示，公司净亏损达8亿美元，折合每股收益为-1.97美元。这一数字，相较于市场通过IBES调查所预估的-2.08美元，表现略胜一筹。季度数据源自该公司于7月31日发布的官方财务报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4548","BK4532","BK4501","LGHT","MRNA","BK4139","GNOM","BK4588","MRNY","BK4585","BK4533","WDNA","IDNA","MRNX","BK4568","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368109","title":"Moderna(MRNA.US)盤前跌5.7%二季度營收略低於預期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368109?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:04","pubTimestamp":1785495856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4568","BK4548","MRNA","MRNX","BK4139","BK4585","LGHT","WDNA","MRNY","GNOM","IDNA","BK4501","BK4533","BK4532","BK4588","BK4551","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113092299","title":"Moderna宣佈：mRNA-1403 III期中期分析未達早期成功統計標準，正籌備新增隊列招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1113092299","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113092299?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:02","pubTimestamp":1785495775,"startTime":"0","endTime":"0","summary":"Moderna公司披露，其mRNA-1403候选药物在III期临床试验的中期分析中，并未达到预设的早期成功统计阈值。这一结果意味着，该药物未能展现出足以支撑其提前获批的显著疗效。尽管如此，公司并未止步于此。Moderna目前正紧锣密鼓地筹备，计划增设一个额外的受试者队列，以期进一步评估该药物的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4533","MRNX","BK4501","BK4139","BK4548","IDNA","LGHT","GNOM","BK4588","MRNA","BK4568","MRNY","BK4534","BK4532","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145717315","title":"Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點","url":"https://stock-news.laohu8.com/highlight/detail?id=1145717315","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145717315?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:02","pubTimestamp":1785495774,"startTime":"0","endTime":"0","summary":"Moderna公司近日释放积极信号，预计其第五款产品——针对Mflusiva的疗法，有望在今年8月5日的PDUFA日期获得监管批准。这一日期标志着FDA对该药物申请的最终审查期限，若顺利通关，将成为Moderna产品管线中的又一重要里程碑。目前，市场正密切关注这一审批进程，期待它为生物医药领域注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4568","BK4533","BK4588","BK4534","LGHT","BK4585","BK4548","MRNY","MRNX","IDNA","BK4501","GNOM","BK4551","BK4532","MRNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655334630","title":"【特約大V】龔成：最新分析，6個高增長行業","url":"https://stock-news.laohu8.com/highlight/detail?id=2655334630","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655334630?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 13:21","pubTimestamp":1785475308,"startTime":"0","endTime":"0","summary":"行业现仍处于发展阶段。目前持有超过400万枚以太币。这不仅节省长期用药开支，更大幅改善病人生活品质，市场价值极高。研发成功可赚取巨利，失败则股价大跌。绝大部分尚未有商业化产品，无明显收入，持续烧钱下资金链可能出现问题。--6. 核能：AI数据中心的电力答案--最后一个行业是核能产业。受惠于碳中和趋势及AI数据中心的庞大用电需求，核能正快速增长。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987233","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0499858602.USD","LU2168564495.EUR","BK4543","LU0672654240.SGD","LU0871576103.HKD","LU2092937221.SGD","LU0011850046.USD","IE0034224299.USD","LU2152927971.USD","LU2468319806.SGD","LU0082616367.USD","LU2213496289.HKD","LU0051755006.USD","LU0208291251.USD","LU1303367103.USD","BK4554","LU1791807156.HKD","LU1429558221.USD","SG9999002463.SGD","LU0605514214.HKD","QBY","LU0345775950.USD","LU2476274308.USD","IE00BQXX3C00.GBP","LU1481107354.HKD","LU0345769631.USD","LU1981816686.USD","LU2720916845.USD","LU1978683503.SGD","BITQ","BK1575","CRCA","BEAM","LU0348814723.USD","LU2168563687.JPY","LU2471134523.USD","LU2168564222.USD","LU0957791311.USD","LU1839511570.USD","GNOM","LU0432979614.USD","LU2778985437.USD","TSLZ","RGTX","LU1861217088.USD","WQTM","LU0054450605.USD","LU0345776255.USD","LU2097828805.USD","LU2543165471.USD","CRCL","LU2097828631.EUR","LU2360107168.USD","LU1794554557.SGD","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU0449515922.USD","07366","LU0456846285.SGD","LU2471134952.CNY","LU0918141887.USD","LU0345770993.USD","LU0169518387.USD","BK4604","BK1502","BK1521","LU0254981946.USD","LU1989771016.USD","IE00BWXC8680.SGD","LU0327786744.USD","LU2456880835.USD","TLA","BMNG","BK4505","TSYY","COIN","LU1813983027.USD","TRUI","LU0675040207.SGD","TSLP","LU1267930730.SGD","BK4608","BK1589","LU0634319403.HKD","IE00BSNM7G36.USD","LU1435385759.SGD","LU2257852520.SGD","BK4023","CRCG","LU0039217434.USD","LU1303224171.USD","COIA","FDIG","LU0823413660.USD","BKCH","FMED","LU1983299246.USD","XME","IE00BK4W5M84.HKD","LU1961090484.USD","IE00B2B36J28.USD","FRNW","IE0034235188.USD","09766","LU1153585028.USD","BK4606","QBTZ","IE0004086264.USD","BK1607","LU0210536198.USD","LU2290526834.HKD","LU0234570918.USD","XIACY","LU0823416689.USD","LU1188198961.HKD","LU2750360641.GBP","LU1923622291.USD","LU0326950275.SGD","HRTS","LU2264538146.SGD","LU2108987350.USD","SMRF","TSII","CCUP","IE00B3M56506.USD","BK4516","LU2065171311.SGD","UXI","LU2168564065.EUR","ILMN","LU1105468828.SGD","YBMN","LIT","BK4563","BK4611","LU1551013425.SGD","BK4511","LU1914381329.SGD","LU0499858438.USD","LU0918141705.HKD","BK4585","LU0053666078.USD","LU0719512351.SGD","SG9999015978.USD","LU0417516738.SGD","URAN","LU0531970944.HKD","LU0029874061.USD","LU1719994722.HKD","RGTZ","TSLQ","LU2226246903.HKD","QBTX","LU0114720955.EUR","LU1861215975.USD","GNMX","BK1193","BK4147","HK0000165453.HKD","DAPP","LU0231483743.USD","LU1861220033.SGD","CRCD","LU0823414551.USD","LU1551013342.USD","LU2360108059.USD","LU0348723411.USD","LU0211977185.USD","LU2168564149.EUR","TESL","LU0214875030.USD","LU0149721374.USD","LU0528227936.USD","LU1291159041.SGD","LU1861559042.SGD","LU2476274720.SGD","LU0882574055.USD","ICRC","LU1670627923.USD","IE00BJJMRZ35.SGD","LU2360107671.USD","09880","81810","BLCK","LU1815333072.USD","LU0708995583.HKD","IONQ","LU2211815571.USD","LU2399975544.HKD","QBTS","CONL","LU0143863198.USD","TSLT","LU1923621640.USD","BK4099","COIG","LU0061474960.USD","QTUP","LU0128526141.USD","LU0345769128.USD","BK1613","LU1548497426.USD","TSLS","IOYY","LU1057294990.SGD","BK4081","LU1868837565.USD","LU2764262908.HKD","IE0002141913.USD","LU1066053197.SGD","BK4170","LU1808992512.USD","LU2326559502.SGD","LU0588546209.SGD","LU0700851271.USD","LU0964807845.USD","BK4533","LEUX","IE0032431581.USD","LU1323998911.USD","BK4551","TEST","TSLR","TSLO","IE00BK4W5L77.USD","LU0417516902.SGD","LU2236285917.USD","BMNR","BK4121","BK4534","LU1854104046.USD","BK4596","IE00BJLML261.HKD","LU2039709279.SGD","MIUmain","LU0540923850.HKD","LU2360106780.USD","OKLS","TSLY","LU1061106388.HKD","LU0823040885.USD","RCTR","LU0823397103.USD","LU2750360997.AUD","LU0345770308.USD","LU0235996351.USD","LU1366192091.USD","LU1145028129.USD","LU1066051225.USD","BK4539","BK4595","GB00BDT5M118.USD","LU2065171402.SGD","LU0823039010.USD","GEVX","RGYY","LU1712237335.SGD","LU0594300419.USD","FINX","LU0320765489.SGD","LU2097828557.USD","LU0463099449.HKD","LU0097036916.USD","LU0143863784.USD","LU0348816934.USD","BK4527","LU2125909916.SGD","SG9999003461.SGD","IE00BJT1NW94.SGD","IONZ","LU1720051108.HKD","LU2764263039.SGD","NUKX","BK4602","LU1633808545.USD","BK4574","01810","LU0823041008.USD","ICOI","CONX","JOUL","LU1066051498.USD","LU2097828714.EUR","BK4581","LU1282648689.USD","LU0070302665.USD","LU0557290698.USD","LU2756315318.SGD","LU2298322129.HKD","LU1280957306.USD","LU2125909593.SGD","LU2764263203.CNY","LU1880383440.USD","LU0820561818.USD","IE00B1BXHZ80.USD","LU2041044095.USD","IE00B1XK9C88.USD","LU2471134879.HKD","LU0164880469.USD","LU0689472784.USD","BK1618","LU0823411888.USD","09366","LU0084288322.USD","BK4139","LU0611395673.USD","LU0820561909.HKD","BK4156","IE00B19Z9505.USD","LU0724618433.USD","IONX","LU0640476718.USD","CRSH","CONY","OKLO","LU0348827113.USD","LU1988902786.USD","TSLI","LU2420271590.USD","GEV","LU0466842654.USD","LU1623119135.USD","POWR","LU0109391861.USD","LU0320765059.SGD","LU0244354667.USD","LU0797268264.HKD","LU2249611893.SGD","LU2097828474.EUR","LU0117841782.USD","LU2756315664.SGD","IBLC","LU0820562030.AUD","EXI","LU1670628061.USD","LU0823414478.USD","URNJ","CRCO","LU0164865239.USD","LU1861220207.SGD","LU0359201612.USD","LU1720051017.SGD","LU2403377893.USD","LU0823413587.USD","07766","LU2211814178.USD","LU1668664300.SGD","IONL","LU0348735423.USD","COYY","LU0266013472.USD","LU2294711713.HKD","LU0348825331.USD","BK4141","LU0342679015.USD","LU2089984988.USD","LU2125910179.SGD","IE00BQXX3D17.EUR","LU0593848301.USD","RGTU","LU0307460666.USD","IE00BKPKM429.USD","BMNU","LU2298321311.HKD","SG9999001093.SGD","TSL","LU2065170008.USD","BK4535","LU1770034418.SGD","OKLL","LU0198837287.USD","LU0823426308.USD","CRPT","LU0164872284.USD","LU0133085943.USD","WATS","LU2087589342.USD","BK4566","LU1093756325.SGD","DRGN","IE00B19Z8X17.USD","LU0650527681.SGD","LU1064131342.USD","LU0323591593.USD","WANT","BK4591","LU1868838027.USD","LU0441854154.USD","LU1880383366.USD","BK4600","LU1861558580.USD","LU1232071149.USD","COII","LU0708995401.HKD","NLR","LU2125910336.SGD","PUI","LU0823397285.USD","BK4548","URA","TSLL","LU0234572021.USD","LU1803068623.USD","LU1854103824.USD","BK4598","LEU","LU0210526637.USD","UUUG","LU0052750758.USD","IE00BQXX3F31.USD","TMO","LU0456827905.SGD","LU2098885051.SGD","TSLW","IE00B4R5TH58.HKD","LU2294711473.HKD","LU0096362180.USD","HK0000286598.CNH","LU2065169927.USD","SG9999015986.USD","UUUU","LU1778281490.HKD","HK0000914686.HKD","LU0077335932.USD","LU1791710582.SGD","LU0449509016.USD","LU2063271972.USD","LU2250418816.HKD","LU2125909759.SGD","RGTI","LU1791710400.SGD","BK1523","BK4555","URNM","LU0122379950.USD","COIW","LU1093756168.USD","TMED","LU0943347566.SGD","GEVG","LU1956131251.USD","LU1720050803.USD","SMOG","BK4612","LU2112291526.USD","COIO","FIAT","FDRV","SG9999015952.SGD","LU0823426480.USD","GASZ","SG9999015945.SGD","TSDD","LU2023250330.USD","LU2417539215.USD","LU2462157665.USD","BMNZ","LU1674673428.USD","LU0572944931.SGD","LU0320764599.SGD","LU2506951792.HKD","LU1770036033.HKD","LU1251922891.USD","CNRG","BK4550","LU1023059063.AUD","CONI","LU2896262040.SGD","LU2125909247.SGD","LU0359202008.SGD","BK4592","LU0124384867.USD","LU1923622614.USD","LU0359201885.HKD","LU0316494557.USD","LU2602419157.SGD","IE00B19Z8W00.USD","BK4588","IE0004091025.USD","LU0531971595.HKD","BK1610","LU2433249047.HKD","BK1183","HK0000914660.USD","LU0594300179.USD","IE0009355771.USD","BK1615","LU0314109678.HKD","HXXD.SI","LU1629891620.HKD","LU2087621335.USD","LU2471134796.USD","PACB","LU1852331112.SGD","BK4182","LU0823038988.USD","BK4112","BK4556","LU0561508036.HKD","LU2357125470.USD","IDRV","CQTM","BK1506","IE0034235303.USD","LU1328277881.USD","LU0056508442.USD","TSLA","LU2357305700.SGD","TSLG","LU1674673691.USD","LU1023057109.AUD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800659","title":"今日關注要點——7月31日（星期五）","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800659","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655800659?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 02:30","pubTimestamp":1785436236,"startTime":"0","endTime":"0","summary":"今日关注要点——7月31日（星期五）《今日要闻》是一份通过电子邮件和PDF形式发布的刊物，内容涵盖当日主要新闻、事件、分析及其他专题报导。消费品制造商Church & Dwight则预计受需求疲软影响，第二季度营收将出现下滑。投资者将关注其新冠疫苗的销售情况，以及全年利润预期的任何调整。在加拿大经济方面，加拿大统计局计划发布5月份国内生产总值数据，预计将增长0.2%，此前为增长0.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL4T43W2IR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","LU2430703095.HKD","LU2237438978.USD","LU0878866978.SGD","CHD","IE00B1XK9C88.USD","IYE","WEEI","GPZ","GXPE","XOMZ","DIG","LU2430703251.USD","CL","BEN","MRNY","TRUN","LU0690374615.EUR","BK4592","LU0971096721.USD","LU0266013472.USD","LGHT","IE00BLSP4452.SGD","FENY","MRNA","VDE","TEXU","BK4581","PRVT","DRLL","IGE","XLE","AAUM","ERX","XOMO","SG9999002224.SGD","LBO","IXC","FTXN","XOMX","WDNA","LU1496350171.SGD","GNOM","XOM","CVX","OILT","ARES","LU1066053197.SGD","LU1074936037.SGD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655842772","title":"默克、惠康與一家全球衞生組織合作，共同研製埃博拉疫苗以用於臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2655842772","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655842772?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 13:03","pubTimestamp":1785387832,"startTime":"0","endTime":"0","summary":"默克与惠康基金会的合作将推动国际艾滋病疫苗倡议组织研发的单剂量疫苗的生产，世界卫生组织今年5月曾将其列为最具前景的候选疫苗。希勒曼公司将利用IAVI提供的起始原料，生产可用于早期临床试验的成品疫苗剂量。默克公司传染病与疫苗研发负责人塔里特·穆科帕迪亚在接受采访时表示，疫苗剂量有望在今年年底前准备就绪，用于临床试验。穆科帕迪亚表示，希勒曼实验室具备生产数万剂疫苗的能力，这应足以满足试验需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL4S43W0CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","XLV","SG9999014559.SGD","RXL","LU1066051225.USD","MRNY","MRNA","LU0965509101.SGD","BK4585","BK4548","LU0234572021.USD","LU2357627491.SGD","SG9999001176.USD","LU2468319806.SGD","LU0203345920.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IHE","LU0320765489.SGD","LU2106854487.HKD","LU0208291251.USD","LU0124676726.USD","LU0211331839.USD","IE00BBT3K403.USD","LU0477156953.USD","LU1037948541.HKD","IE00B4R5TH58.HKD","SG9999013999.USD","IXJ","IE00BJT1NW94.SGD","MRNX","SG9999002224.SGD","LU0320765646.SGD","LU1066051498.USD","LU0965508806.USD","LU0006306889.USD","GDOC","LU0070302665.USD","GNOM","LU0432979614.USD","LU0106261372.USD","LU1291159041.SGD","LU2125909593.SGD","LU0980610538.SGD","IE00B1BXHZ80.USD","LU1989772840.SGD","LU0265550946.USD","LU1116320737.USD","LU1917777945.USD","IE00BJJMRZ35.SGD","LGHT","LU0265550359.USD","SG9999015358.SGD","LU0122379950.USD","LU1093756168.USD","LU2361044865.SGD","LU0238689110.USD","SG9999001440.SGD","BK4139","WDNA","IE00BFTCPJ56.SGD","LU0689626769.HKD","IE00BLSP4239.USD","LU1066051811.HKD","SG9999014567.USD","SG9999014575.USD","LU0859254822.USD","LU2023250504.SGD","LU2112291526.USD","LU0289739699.SGD","FTXH","TRUH","LU1989771016.USD","BK4532","BK4559","LU0130102774.USD","PPH","MRK","FHLC","LU1941712348.USD","LU0965509283.SGD","LU1057294990.SGD","LU1934455194.USD","SG9999014542.SGD","LU0942090050.USD","LU2023250843.SGD","LU0098860793.USD","IE0002141913.USD","LU1571399168.USD","LU0868494708.USD","LU1066053197.SGD","BK4550","IE00BSNM7G36.USD","LU1069347547.HKD","LU1023059063.AUD","LU1989772923.USD","LU2125154935.USD","LU2125909247.SGD","BMED","LU0861579265.USD","LU1923622614.USD","LU1585245621.USD","LU2360032135.SGD","BK4533","SG9999015341.SGD","IE00BLSP4452.SGD","LU0266013472.USD","BK4588","LU1974910355.USD","IE00BN8TJ469.HKD","LU0648001328.SGD","BK4551","LU1116320901.HKD","IDNA","LU2089984988.USD","LU1983299246.USD","LU2461242641.AUD","LU2433249047.HKD","LU1037948897.HKD","LU0203347892.USD","LU1699723380.USD","IE00B2B36J28.USD","LU2324357040.USD","BK4534","LU2361045086.USD","BK4501","IE0009355771.USD","LU1430594728.SGD","LU1934455863.HKD","LU1941712264.USD","LU2361044949.HKD","SG9999002232.USD","LU1035773651.USD","LU0985320562.USD","LU1162221912.USD","VHT","LU1929549753.HKD","LU1093756325.SGD","IYH","LU2491049909.HKD","LU1934455277.USD","HRTS","LU0058720904.USD","LU2491050071.SGD","LU2491050154.USD","BK4568","LU1061106388.HKD","BK4007","SG9999001176.SGD","BK4516","LU0130517989.USD","LU2125154778.USD","LU0965509010.AUD","LU0868494617.USD","PAWZ","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654048086","title":"美國食品藥品監督管理局（FDA）批准了Freenome公司用於結直腸癌篩查的血液檢測","url":"https://stock-news.laohu8.com/highlight/detail?id=2654048086","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654048086?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 21:13","pubTimestamp":1785157998,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局批准了Freenome公司用于结直肠癌筛查的血液检测路透7月27日-两家公司周一表示，美国食品药品监督管理局已批准Freenome公司针对年龄较大的成年人的FRNM.O血液结直肠癌筛查检测，为合作伙伴雅培公司今秋在美国推出该产品铺平了道路。美国食品药品监督管理局批准该检测适用于45岁及以上中风险成年人，这使Freenome拥有了其首个商业化产品。根据2025年签署的商业化协议，Freenome将从雅培公司获得与此次批准相关的1亿美元里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4T43T12N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1989763427.SGD","SG9999002224.SGD","BK4551","SG9999002232.USD","EKG","SGXZ23171101.USD","LU1061106388.HKD","SG9999004303.SGD","LU2133065610.SGD","LU2237957811.SGD","BK4566","BK4533","GH","ABT","BK4568","LU0889565916.HKD","LU2237957902.USD","LU1989763690.USD","LU1721429741.USD","LU0170899867.USD","LU1914381329.SGD","LFSC","HELX","LU0266013472.USD","BK4585","LU0234572021.USD","BK4082","BK4588","GNMX","LU0882574055.USD","IE00B2B36J28.USD","GNOM","LU0432979614.USD","IHI","LU2468319806.SGD","LU0320765992.SGD","LU2112291526.USD","IE0002141913.USD","FRNM","LU0122379950.USD","PTH","LU0058720904.USD","TMED","LU2211815571.USD","LU0868494617.USD","GDOC","FFOX","PJP","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036699","title":"美股異動 | CRISPR基因編輯公司Scribe Therapeutics(SCTX.US)登陸美股市場 開盤後升逾59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036699?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 23:57","pubTimestamp":1784908651,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WDNA","SYNB","BK4539","GNOM","BK4556","XT","HELX","LU1861558580.USD","TARK","BK4588","BK4007","BK4139","FWD","BK4611","IDNA","SCTX","NBDS","LU1861559042.SGD","BK4585","BMED","ARKG","DTEC","LENZ","CRSP","KOMP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":198,"code":"91000000","status":"200"}]}}